Genetype - Unlocking personalised preventative health
Genetic Technologies (ASX: GTG, NASDAQ Global Market: GENE) is a leader in the development and commercialisation of genetic risk assessment technology.
 
Significant progress has been made in understanding the role of hereditary risk in chronic disease, however, many chronic conditions cannot be predicted by this risk alone. 
 
We’re transforming the conversation. Transitioning from a one-size-fits-all model to personalised, predictive health assessment – where each person has the information, they need to manage their health according to their own risk.
 
Backed by over 20 years of experience, our doctors, scientist and technicians are translating genetic information into multi-tests that uniquely combine genetic and clinical risk models to predict risk of chronic diseases before onset.
 
We’re empowering physicians to improve health outcomes for people around the world. Tracking disease to its source. Enabling a new era of personalised medicine.

Life Sciences

Health Care

Biotechnology

GeneType

Carl Stubbings

Diyana Samad

Bronwyn Christie

Vicki Jacques

Nick Burrows

Richard Allman

The Leadership Team at GeneType drives the company's strategic direction and oversees its mission to revolutionize preventative health through personalized genetic risk assessment. Comprising top executives with expertise in science, finance, commercial initiatives, and enterprise sales, this team collaborates to enhance innovative solutions and optimize operational efficiency, ultimately empowering healthcare providers and patients with actionable insights for better health outcomes.

Leadership Team

Sales and Marketing

Scientific and Regulatory Affairs

Leadership Team

About

Team members

Other teams at GeneType

Sales and Marketing

Scientific and Regulatory Affairs